TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: COLOFOL - A Pragmatic Study to Assess the Frequency of Surveillance Tests After Curative Resection in Patients With Stage II and III Colorectal Cancer - a Randomised Multicentre Trial
Brief Summary: The aim is to conduct a prospective multicentre randomised study comparing two different control regimens after resection for colorectal cancer stage II - III. Follow-up after surgery for colorectal cancer is a controversial issue. The reasons for follow-up are: to obtain a better overall survival, for scientific purposes and/or for psychological reasons and/or as quality assessment. Meta-analyses of randomised controlled studies have lately shown that a beneficial effect on the overall mortality could be found with intense follow-up compared to sporadic. This study compares the regimen of CT-scan or MR scan of the liver, control of the carcinoembryonic antigen (CEA), and CT-scan or X-ray of the lungs in two groups with either control after 12 and 36 months, or after 6, 12, 18, 24, and 36 months. The efficacy parameters are total and cancer-specific mortality.


Options:
A: Arm Label: intervention group; Type: ACTIVE_COMPARATOR; Interventions: Device: distress thermometer | Arm Label: control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: distress thermometer; Assigned to Arm(s): intervention group
B: Arm Label: 1 frequent control; Type: ACTIVE_COMPARATOR; Interventions: Procedure: CT-scan, CEA, X-ray of lungs | Arm Label: 2 less frequent control; Type: OTHER; Interventions: Procedure: CT-scan, CEA, X-ray of lungs | Intervention Type: PROCEDURE; Name: CT-scan, CEA, X-ray of lungs; Assigned to Arm(s): 1 frequent control | Intervention Type: PROCEDURE; Name: CT-scan, CEA, X-ray of lungs; Assigned to Arm(s): 2 less frequent control
C: Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Other: PET-TDM for current indication | Arm Label: 1; Type: EXPERIMENTAL; Interventions: Other: semi-annual systematic PET-TDM | Intervention Type: OTHER; Name: semi-annual systematic PET-TDM; Assigned to Arm(s): 1 | Intervention Type: OTHER; Name: PET-TDM for current indication; Assigned to Arm(s): 2
D: Arm Label: Survivorship Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Survivorship Intervention | Arm Label: Facing Forward; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Facing Forward | Intervention Type: BEHAVIORAL; Name: Survivorship Intervention; Assigned to Arm(s): Survivorship Intervention | Intervention Type: BEHAVIORAL; Name: Facing Forward; Assigned to Arm(s): Facing Forward

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Trial of Ibuprofen Injection (IVIb) for Treatment of Pain in the Post-Operative Adult Patients
Brief Summary: The primary objective of this study of Caldolor (IV ibuprofen) administered to post-operative hospitalized adult patients every 6 hours for 48 hours is to determine the efficacy of Caldolor compared to placebo for the treatment of post-operative pain as measured by reduction in the requirement for the narcotic analgesic, morphine, post surgery


Options:
A: Arm Label: ibuprofen( 400mg group); Type: EXPERIMENTAL; Interventions: Drug: ibuprofen | Arm Label: ibuprofen( 800mg group); Type: EXPERIMENTAL; Interventions: Drug: ibuprofen | Arm Label: placebo group; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: ibuprofen; Assigned to Arm(s): ibuprofen( 400mg group), ibuprofen( 800mg group) | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): placebo group
B: Arm Label: intravenous ibuprofen; Type: ACTIVE_COMPARATOR; Interventions: Drug: Intravenous ibuprofen | Arm Label: normal saline; Type: PLACEBO_COMPARATOR; Interventions: Other: Normal saline as placebo comparator | Intervention Type: OTHER; Name: Normal saline as placebo comparator; Assigned to Arm(s): normal saline | Intervention Type: DRUG; Name: Intravenous ibuprofen; Assigned to Arm(s): intravenous ibuprofen
C: Arm Label: Maxigesic IV; Type: EXPERIMENTAL; Interventions: Drug: Maxigesic IV | Arm Label: IV Acetaminophen; Type: ACTIVE_COMPARATOR; Interventions: Drug: IV Acetaminophen | Arm Label: IV Ibuprofen; Type: ACTIVE_COMPARATOR; Interventions: Drug: IV Ibuprofen | Arm Label: Placebo IV; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo IV | Intervention Type: DRUG; Name: Maxigesic IV; Assigned to Arm(s): Maxigesic IV | Intervention Type: DRUG; Name: IV Acetaminophen; Assigned to Arm(s): IV Acetaminophen | Intervention Type: DRUG; Name: IV Ibuprofen; Assigned to Arm(s): IV Ibuprofen | Intervention Type: DRUG; Name: Placebo IV; Assigned to Arm(s): Placebo IV
D: Arm Label: IV Caldolor (ibuprofen); Type: ACTIVE_COMPARATOR; Interventions: Drug: IV Caldolor | Arm Label: standard treatment group; Type: PLACEBO_COMPARATOR; Interventions: Drug: IV Placebo | Intervention Type: DRUG; Name: IV Caldolor; Assigned to Arm(s): IV Caldolor (ibuprofen) | Intervention Type: DRUG; Name: IV Placebo; Assigned to Arm(s): standard treatment group

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Trial of Ibuprofen Injection (IVIb) for Treatment of Pain in the Post-Operative Adult Patients
Brief Summary: The primary objective of this study of Caldolor (IV ibuprofen) administered to post-operative hospitalized adult patients every 6 hours for 48 hours is to determine the efficacy of Caldolor compared to placebo for the treatment of post-operative pain as measured by reduction in the requirement for the narcotic analgesic, morphine, post surgery


Options:
A: Arm Label: placebo group; Type: PLACEBO_COMPARATOR; Interventions: Drug: Ketoprofen | Arm Label: ketopofen quarter dose; Type: OTHER; Interventions: Drug: Ketoprofen | Arm Label: ketoprofen half-dose; Type: OTHER; Interventions: Drug: Ketoprofen | Arm Label: Ketoprofen full dose; Type: OTHER; Interventions: Drug: Ketoprofen | Intervention Type: DRUG; Name: Ketoprofen; Assigned to Arm(s): Ketoprofen full dose, ketopofen quarter dose, ketoprofen half-dose, placebo group
B: Arm Label: Ketorolac; Type: EXPERIMENTAL; Interventions: Drug: Ketorolac | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Ketorolac; Assigned to Arm(s): Ketorolac | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: Active Clonidine and Active ASA; Type: EXPERIMENTAL; Interventions: Drug: Active Clonidine, Drug: Active ASA | Arm Label: Active Clonidine and Placebo ASA; Type: EXPERIMENTAL; Interventions: Drug: Active Clonidine, Drug: Placebo ASA | Arm Label: Placebo Clonidine and Active ASA; Type: EXPERIMENTAL; Interventions: Drug: Placebo Clonidine, Drug: Active ASA | Arm Label: Placebo Clonidine and Placebo ASA; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo Clonidine, Drug: Placebo ASA | Intervention Type: DRUG; Name: Active Clonidine; Assigned to Arm(s): Active Clonidine and Active ASA, Active Clonidine and Placebo ASA | Intervention Type: DRUG; Name: Placebo Clonidine; Assigned to Arm(s): Placebo Clonidine and Active ASA, Placebo Clonidine and Placebo ASA | Intervention Type: DRUG; Name: Active ASA; Assigned to Arm(s): Active Clonidine and Active ASA, Placebo Clonidine and Active ASA | Intervention Type: DRUG; Name: Placebo ASA; Assigned to Arm(s): Active Clonidine and Placebo ASA, Placebo Clonidine and Placebo ASA
D: Arm Label: intravenous ibuprofen; Type: ACTIVE_COMPARATOR; Interventions: Drug: Intravenous ibuprofen | Arm Label: normal saline; Type: PLACEBO_COMPARATOR; Interventions: Other: Normal saline as placebo comparator | Intervention Type: OTHER; Name: Normal saline as placebo comparator; Assigned to Arm(s): normal saline | Intervention Type: DRUG; Name: Intravenous ibuprofen; Assigned to Arm(s): intravenous ibuprofen

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: An Open-Label Titration Followed by a Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Tolerability, and Safety of Oxymorphone Extended Release Tablets in Opioid-Naïve Patients With Chronic Low Back Pain
Brief Summary: The purpose of this study is to evaluate the analgesic efficacy and safety of oxymorphone extended release in non-cancer patients with chronic low back pain.


Options:
A: Arm Label: Double-blind BTDS 10 or 20; Type: EXPERIMENTAL; Interventions: Drug: Buprenorphine transdermal system | Arm Label: Double-blind Placebo TDS; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Buprenorphine transdermal system; Assigned to Arm(s): Double-blind BTDS 10 or 20 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Double-blind Placebo TDS
B: Intervention Type: DRUG; Name: OROS Hydromorphone HCI; Assigned to Arm(s): N/A
C: Intervention Type: DRUG; Name: Oxymorphone Extended Release; Assigned to Arm(s): N/A
D: Intervention Type: DRUG; Name: CG 5503;tapentadol; Assigned to Arm(s): N/A

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Rectal and Oral Omeprazole Treatment of Gastroesophageal Reflux in Infants With Esophageal Atresia or Congenital Diaphragmatic Hernia; A Pharmacodynamic and Pharmacokinetic Study.
Brief Summary: The purpose of this study is to compare the efficacy of oral and rectal omeprazole treatment in infants with gastroesophageal reflux due to esophageal atresia or congenital diaphragmatic hernia.


Options:
A: Intervention Type: DRUG; Name: Esomeprazole (Nexium); Assigned to Arm(s): N/A
B: Arm Label: Low dose; Type: ACTIVE_COMPARATOR; Interventions: Drug: pantoprazole sodium enteric-coated spheroid suspension | Arm Label: High dose; Type: ACTIVE_COMPARATOR; Interventions: Drug: pantoprazole sodium enteric-coated spheroid suspension | Intervention Type: DRUG; Name: pantoprazole sodium enteric-coated spheroid suspension; Assigned to Arm(s): High dose, Low dose
C: Intervention Type: DRUG; Name: pantoprazole for approximately 9 weeks.; Assigned to Arm(s): N/A
D: Arm Label: Oral omeprazole; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Rectal omeprazole; Type: ACTIVE_COMPARATOR; Interventions: Drug: Omeprazole rectally 1mg/kg | Intervention Type: DRUG; Name: Omeprazole rectally 1mg/kg; Assigned to Arm(s): Rectal omeprazole

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomised Trial to Establish the Effects of Early Intensive Blood Pressure Lowering on Death and Disability in Patients With Stroke Due to Acute Intracerebral Haemorrhage
Brief Summary: The purpose of the study is to determine whether lowering high blood pressure levels after the start of a stroke caused by bleeding in the brain (intracerebral haemorrhage) will reduce the chances of a person dying or surviving with a long term disability. The study will be undertaken in two phases: a vanguard phase in 400 patients, to plan for a main phase in 2000 patients.


Options:
A: Intervention Type: DRUG; Name: Labetalol Hydrochloride; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Metoprolol tartrate; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Hydralazine Hydrochloride; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Glycerol Trinitrate; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Phentolamine mesylate; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Nicardipine; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Urapidil; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Esmolol; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Clonidine; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Enalaprilat; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Nitroprusside; Assigned to Arm(s): N/A
B: Arm Label: Target systolic BP < 150 mmHg; Type: EXPERIMENTAL; Interventions: Drug: labetalol/hydralazine/enalapril | Arm Label: Target systolic BP < 180 mmHg; Type: ACTIVE_COMPARATOR; Interventions: Drug: labetalol/hydralazine/enalapril | Intervention Type: DRUG; Name: labetalol/hydralazine/enalapril; Assigned to Arm(s): Target systolic BP < 150 mmHg, Target systolic BP < 180 mmHg
C: Arm Label: Intensive BP lowering; Type: OTHER; Interventions: Other: Blood pressure management policies | Arm Label: Guideline recommended BP lowering; Type: OTHER; Interventions: Other: Blood pressure management policies | Intervention Type: OTHER; Name: Blood pressure management policies; Assigned to Arm(s): Guideline recommended BP lowering, Intensive BP lowering
D: Arm Label: Candesartan Cilexetil; Type: EXPERIMENTAL; Interventions: Drug: Candesartan Cilexetil | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Candesartan Cilexetil; Assigned to Arm(s): Candesartan Cilexetil | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomised Trial to Establish the Effects of Early Intensive Blood Pressure Lowering on Death and Disability in Patients With Stroke Due to Acute Intracerebral Haemorrhage
Brief Summary: The purpose of the study is to determine whether lowering high blood pressure levels after the start of a stroke caused by bleeding in the brain (intracerebral haemorrhage) will reduce the chances of a person dying or surviving with a long term disability. The study will be undertaken in two phases: a vanguard phase in 400 patients, to plan for a main phase in 2000 patients.


Options:
A: Arm Label: No intervention; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Induced hypertension; Type: ACTIVE_COMPARATOR; Interventions: Other: Induced hypertension | Intervention Type: OTHER; Name: Induced hypertension; Assigned to Arm(s): Induced hypertension
B: Intervention Type: DRUG; Name: Labetalol Hydrochloride; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Metoprolol tartrate; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Hydralazine Hydrochloride; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Glycerol Trinitrate; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Phentolamine mesylate; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Nicardipine; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Urapidil; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Esmolol; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Clonidine; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Enalaprilat; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Nitroprusside; Assigned to Arm(s): N/A
C: Arm Label: Normal Fluids & Normal Blood Pressure; Type: ACTIVE_COMPARATOR; Interventions: Other: Fluid manipulation, Other: Blood Pressure Manipulation | Arm Label: Increased Fluids & Normal Blood Pressure; Type: ACTIVE_COMPARATOR; Interventions: Other: Fluid manipulation, Other: Blood Pressure Manipulation | Arm Label: Normal Fluids & Higher Blood Pressure; Type: ACTIVE_COMPARATOR; Interventions: Other: Fluid manipulation, Other: Blood Pressure Manipulation | Arm Label: Increased Fluids & Higher Blood Pressure; Type: ACTIVE_COMPARATOR; Interventions: Other: Fluid manipulation, Other: Blood Pressure Manipulation | Intervention Type: OTHER; Name: Fluid manipulation; Assigned to Arm(s): Increased Fluids & Higher Blood Pressure, Increased Fluids & Normal Blood Pressure, Normal Fluids & Higher Blood Pressure, Normal Fluids & Normal Blood Pressure | Intervention Type: OTHER; Name: Blood Pressure Manipulation; Assigned to Arm(s): Increased Fluids & Higher Blood Pressure, Increased Fluids & Normal Blood Pressure, Normal Fluids & Higher Blood Pressure, Normal Fluids & Normal Blood Pressure
D: Arm Label: Clazosentan; Type: EXPERIMENTAL; Interventions: Drug: Clazosentan | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Clazosentan; Assigned to Arm(s): Clazosentan | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Lamotrigine Versus Lithium in Subjects With Bipolar Affective Disorders - a Randomised Study of Prophylactic Effect
Brief Summary: The purpose of this study is to compare lamotrigine with lithium in the long term treatment of bipolar disorder in terms of new episode preventive potentials.


Options:
A: Arm Label: Lithium; Type: ACTIVE_COMPARATOR; Interventions: Drug: Lithium | Arm Label: Divalproex; Type: ACTIVE_COMPARATOR; Interventions: Drug: Divalproex | Arm Label: Lithium plus Quetiapine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Lithium, Drug: Quetiapine | Arm Label: Lithium plus Lamotrigine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Lithium, Drug: Lamotrigine | Arm Label: Divalproex plus Quetiapine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Divalproex, Drug: Quetiapine | Arm Label: Divalproex plus Lamotrigine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Divalproex, Drug: Lamotrigine | Intervention Type: DRUG; Name: Lithium; Assigned to Arm(s): Lithium, Lithium plus Lamotrigine, Lithium plus Quetiapine | Intervention Type: DRUG; Name: Divalproex; Assigned to Arm(s): Divalproex, Divalproex plus Lamotrigine, Divalproex plus Quetiapine | Intervention Type: DRUG; Name: Lamotrigine; Assigned to Arm(s): Divalproex plus Lamotrigine, Lithium plus Lamotrigine | Intervention Type: DRUG; Name: Quetiapine; Assigned to Arm(s): Divalproex plus Quetiapine, Lithium plus Quetiapine
B: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: BW430C(lamotrigine); Type: ACTIVE_COMPARATOR; Interventions: Drug: lamotrigine | Intervention Type: DRUG; Name: lamotrigine; Assigned to Arm(s): BW430C(lamotrigine) | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: Arm 1; Type: OTHER; Interventions: Drug: lamotrigine | Intervention Type: DRUG; Name: lamotrigine; Assigned to Arm(s): Arm 1
D: Intervention Type: DRUG; Name: lithium or lamotrigine; Assigned to Arm(s): N/A

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Early vs Late Introduction of Antiretroviral Therapy in Naive HIV-infected Patients With Tuberculosis in Cambodia
Brief Summary: In Cambodia the prevalence of both tuberculosis (TB) and Human Immunodeficiency Virus (HIV) infection is high. Data suggest that aggressive management of HIV infection, which includes Anti-Retroviral Therapy (HAART) during treatment of TB, decreases both morbidity and mortality. On the other hand, the use of HAART for patients with TB may cause severe complications due to drug-drug interactions, and occasionally a temporary exacerbation of symptoms. These reactions may be particularly severe when HAART is started soon after the start of TB treatment.

The proposed study aims to determine the optimal time to initiate HAART in previously untreated HIV-infected adult patients with TB and low CD4 cell counts.


Options:
A: Arm Label: Immediate ARV treatment initiation; Type: EXPERIMENTAL; Interventions: Drug: Immediate ARV treatment initiation with TDF/FTC/EFV | Arm Label: South African recommendation guided ARV initiation; Type: OTHER; Interventions: Other: South African recommendation guided ARV (TDF/FTC/EFV) initiation | Intervention Type: DRUG; Name: Immediate ARV treatment initiation with TDF/FTC/EFV; Assigned to Arm(s): Immediate ARV treatment initiation | Intervention Type: OTHER; Name: South African recommendation guided ARV (TDF/FTC/EFV) initiation; Assigned to Arm(s): South African recommendation guided ARV initiation
B: Arm Label: MJAP Clinics Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: START | Arm Label: MJAP Clinics Pre-Intervention; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: START; Assigned to Arm(s): MJAP Clinics Intervention
C: Intervention Type: DRUG; Name: Emtricitabine/tenofovir disoproxil fumarate; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Lopinavir/ritonavir; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Stavudine; Assigned to Arm(s): N/A
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Procedure: Early antiretroviral treatment | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Late antiretroviral treatment | Intervention Type: PROCEDURE; Name: Early antiretroviral treatment; Assigned to Arm(s): 1 | Intervention Type: PROCEDURE; Name: Late antiretroviral treatment; Assigned to Arm(s): 2

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Examination and Treatment of Elderly After a Fall- an Analysis in a Medical Technology Evaluation Perspective
Brief Summary: Falls and injurious falls are common among elderly people. The aim of the study is to test a model of multifactorial fall intervention in a Danish population of elderly sustaining a fall. Focus is on prevention of further falls, patients views on fall prevention and a cost-effectiveness analysis.


Options:
A: Arm Label: observational; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Exercise group; Type: EXPERIMENTAL; Interventions: Other: Exercise intervention | Intervention Type: OTHER; Name: Exercise intervention; Assigned to Arm(s): Exercise group
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Other: multifactorial intervention | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Other: Usual care | Intervention Type: OTHER; Name: multifactorial intervention; Assigned to Arm(s): 1 | Intervention Type: OTHER; Name: Usual care; Assigned to Arm(s): 2
C: Arm Label: exercise with vitamin D 800 IU/d; Type: EXPERIMENTAL; Interventions: Dietary Supplement: exercise and vitamin D supplementation | Arm Label: exercise with placebo; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: exercise and vitamin D supplementation | Arm Label: no exercise with vitamin D 800 IU/d; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: exercise and vitamin D supplementation | Arm Label: no exercise with placebo; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: exercise and vitamin D supplementation | Intervention Type: DIETARY_SUPPLEMENT; Name: exercise and vitamin D supplementation; Assigned to Arm(s): exercise with vitamin D 800 IU/d | Intervention Type: DIETARY_SUPPLEMENT; Name: exercise and vitamin D supplementation; Assigned to Arm(s): exercise with placebo | Intervention Type: DIETARY_SUPPLEMENT; Name: exercise and vitamin D supplementation; Assigned to Arm(s): no exercise with vitamin D 800 IU/d | Intervention Type: DIETARY_SUPPLEMENT; Name: exercise and vitamin D supplementation; Assigned to Arm(s): no exercise with placebo
D: Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Experimental group; Type: EXPERIMENTAL; Interventions: Other: Interdisciplinary intervention program | Intervention Type: OTHER; Name: Interdisciplinary intervention program; Assigned to Arm(s): Experimental group

Answer: B